1 Min Read
Oct 23 (Reuters) - TIGENIX NV:
* REG-TIGENIX GRANTED ORPHAN DRUG DESIGNATION FROM THE U.S. FDA FOR CX601 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.